Preeclampsia risk after egg donation and the role of immune genes
Part of Women’s health & pregnancy clinical trials.
This study looks at why women who use donated eggs may have a higher risk of preeclampsia (a pregnancy complication with high blood pressure) by examining specific genetic markers (HLA-C and KIR) in the mother, baby, and donor. By joining, you help researchers understand and potentially improve care for future mothers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a live birth after using donated eggs (oocyte donation).
- Genetic test results (HLA-C and KIR) are available for you, the baby, and the egg donor.
- All three parties must have their test results available to join.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether women who become pregnant after receiving donated eggs have a higher risk of developing pre-eclampsia (a serious blood pressure condition) during pregnancy. It aims to understand risks so doctors can better support pregnant women.
This research study follows pregnant people with preeclampsia (a serious blood-pressure condition in pregnancy) to understand how it develops and affects both mother and baby. By participating, you help doctors learn more about this condition and potentially improve care for future patients.
This study looks at how certain hormone receptors might be linked to preeclampsia, a pregnancy complication involving high blood pressure. It aims to understand why some women get preeclampsia and could help improve care in the future.
This study collects blood samples and routine pregnancy data to improve early detection of preeclampsia (a serious pregnancy complication). It aims to build a biobank for future research, and you can participate if you are in your first trimester with a single baby.
This study looks at how the immune system works during pregnancy, focusing on women at high risk for preeclampsia. Researchers want to understand immune changes before any treatment is started.
This study collects samples from pregnant people with preeclampsia (a serious pregnancy blood-pressure condition) and from healthy pregnancy controls. Researchers will study tiny particles (“exosomes”) to see how they differ and whether these signals could help explain or improve care for preeclampsia.
Hear when a new Preeclampsia (PE) Risk trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.